161 related articles for article (PubMed ID: 30841920)
1. Histone deacetylase inhibition by Entinostat for the prevention of electrical and structural remodeling in heart failure.
Freundt JK; Frommeyer G; Spieker T; Wötzel F; Grotthoff JS; Stypmann J; Hempel G; Schäfers M; Jacobs AH; Eckardt L; Lange PS
BMC Pharmacol Toxicol; 2019 Mar; 20(1):16. PubMed ID: 30841920
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of class I but not class IIb histone deacetylases exerts cardiac protection from ischemia reperfusion.
Aune SE; Herr DJ; Mani SK; Menick DR
J Mol Cell Cardiol; 2014 Jul; 72():138-45. PubMed ID: 24632412
[TBL] [Abstract][Full Text] [Related]
3. Anti-Fibrotic Effects of Class I HDAC Inhibitor, Mocetinostat Is Associated with IL-6/Stat3 Signaling in Ischemic Heart Failure.
Nural-Guvener H; Zakharova L; Feehery L; Sljukic S; Gaballa M
Int J Mol Sci; 2015 May; 16(5):11482-99. PubMed ID: 25997003
[TBL] [Abstract][Full Text] [Related]
4. Pacing-induced heart failure causes a reduction of delayed rectifier potassium currents along with decreases in calcium and transient outward currents in rabbit ventricle.
Tsuji Y; Opthof T; Kamiya K; Yasui K; Liu W; Lu Z; Kodama I
Cardiovasc Res; 2000 Nov; 48(2):300-9. PubMed ID: 11054476
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase 2-dependent ventricular electrical remodeling in a porcine model of early heart failure.
Syren P; Rahm AK; Schweizer PA; Bruehl C; Katus HA; Frey N; Thomas D; Lugenbiel P
Life Sci; 2021 Sep; 281():119769. PubMed ID: 34186046
[TBL] [Abstract][Full Text] [Related]
6. Entinostat, a novel histone deacetylase inhibitor is active in B-cell lymphoma and enhances the anti-tumour activity of rituximab and chemotherapy agents.
Frys S; Simons Z; Hu Q; Barth MJ; Gu JJ; Mavis C; Skitzki J; Song L; Czuczman MS; Hernandez-Ilizaliturri FJ
Br J Haematol; 2015 May; 169(4):506-19. PubMed ID: 25712263
[TBL] [Abstract][Full Text] [Related]
7. Acute inhibition of the Na(+)/Ca(2+) exchanger reduces proarrhythmia in an experimental model of chronic heart failure.
Milberg P; Pott C; Frommeyer G; Fink M; Ruhe M; Matsuda T; Baba A; Klocke R; Quang TH; Nikol S; Stypmann J; Osada N; Müller FU; Breithardt G; Noble D; Eckardt L
Heart Rhythm; 2012 Apr; 9(4):570-8. PubMed ID: 22075452
[TBL] [Abstract][Full Text] [Related]
8. A new mechanism preventing proarrhythmia in chronic heart failure: rapid phase-III repolarization explains the low proarrhythmic potential of amiodarone in contrast to sotalol in a model of pacing-induced heart failure.
Frommeyer G; Milberg P; Witte P; Stypmann J; Koopmann M; Lücke M; Osada N; Breithardt G; Fehr M; Eckardt L
Eur J Heart Fail; 2011 Oct; 13(10):1060-9. PubMed ID: 21873342
[TBL] [Abstract][Full Text] [Related]
9. Attenuated ventricular β-adrenergic response and reduced repolarization reserve in a rabbit model of chronic heart failure.
Nissen JD; Thomsen MB; Bentzen BH; Diness JG; Diness TG; Jespersen T; Grunnet M
J Cardiovasc Pharmacol; 2012 Feb; 59(2):142-50. PubMed ID: 21992969
[TBL] [Abstract][Full Text] [Related]
10. G-CSF therapy reduces myocardial repolarization reserve in the presence of increased arteriogenesis, angiogenesis and connexin 43 expression in an experimental model of pacing-induced heart failure.
Milberg P; Klocke R; Frommeyer G; Quang TH; Dieks K; Stypmann J; Osada N; Kuhlmann M; Fehr M; Milting H; Nikol S; Waltenberger J; Breithardt G; Eckardt L
Basic Res Cardiol; 2011 Nov; 106(6):995-1008. PubMed ID: 22072114
[TBL] [Abstract][Full Text] [Related]
11. Selective class I histone deacetylase inhibition suppresses hypoxia-induced cardiopulmonary remodeling through an antiproliferative mechanism.
Cavasin MA; Demos-Davies K; Horn TR; Walker LA; Lemon DD; Birdsey N; Weiser-Evans MC; Harral J; Irwin DC; Anwar A; Yeager ME; Li M; Watson PA; Nemenoff RA; Buttrick PM; Stenmark KR; McKinsey TA
Circ Res; 2012 Mar; 110(5):739-48. PubMed ID: 22282194
[TBL] [Abstract][Full Text] [Related]
12. [Molecular mechanism of the changes in ventricular electrical remodeling caused by mechano-electrical feedback in rabbits with congestive heart failure].
Deng J; Chen M; Yang Q; Yu H; Zhang T; Yu Q; Huang D
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Feb; 26(1):50-4. PubMed ID: 19334553
[TBL] [Abstract][Full Text] [Related]
13. Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure.
Kääb S; Nuss HB; Chiamvimonvat N; O'Rourke B; Pak PH; Kass DA; Marban E; Tomaselli GF
Circ Res; 1996 Feb; 78(2):262-73. PubMed ID: 8575070
[TBL] [Abstract][Full Text] [Related]
14. Epigenetically modified cardiac mesenchymal stromal cells limit myocardial fibrosis and promote functional recovery in a model of chronic ischemic cardiomyopathy.
Moore JB; Tang XL; Zhao J; Fischer AG; Wu WJ; Uchida S; Gumpert AM; Stowers H; Wysoczynski M; Bolli R
Basic Res Cardiol; 2018 Nov; 114(1):3. PubMed ID: 30446837
[TBL] [Abstract][Full Text] [Related]
15. Identification of Jun loss promotes resistance to histone deacetylase inhibitor entinostat through Myc signaling in luminal breast cancer.
Tanioka M; Mott KR; Hollern DP; Fan C; Darr DB; Perou CM
Genome Med; 2018 Nov; 10(1):86. PubMed ID: 30497520
[TBL] [Abstract][Full Text] [Related]
16. Triggered activity and automaticity in ventricular trabeculae of failing human and rabbit hearts.
Vermeulen JT; McGuire MA; Opthof T; Coronel R; de Bakker JM; Klöpping C; Janse MJ
Cardiovasc Res; 1994 Oct; 28(10):1547-54. PubMed ID: 8001044
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiological and structural remodeling in heart failure modulate arrhythmogenesis. 1D simulation study.
Gomez JF; Cardona K; Romero L; Ferrero JM; Trenor B
PLoS One; 2014; 9(9):e106602. PubMed ID: 25191998
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Histone Deacetylases Induces K+ Channel Remodeling and Action Potential Prolongation in HL-1 Atrial Cardiomyocytes.
Lugenbiel P; Govorov K; Rahm AK; Wieder T; Gramlich D; Syren P; Weiberg N; Seyler C; Katus HA; Thomas D
Cell Physiol Biochem; 2018; 49(1):65-77. PubMed ID: 30134221
[TBL] [Abstract][Full Text] [Related]
19. Eplerenone-mediated regression of electrical activation delays and myocardial fibrosis in heart failure.
J Cardiovasc Electrophysiol; 2014 May; 25(5):556-577. PubMed ID: 24612029
[TBL] [Abstract][Full Text] [Related]
20. Differences in Functional Expression of Connexin43 and Na
Zhang X; Patel D; Xu Q; Veenstra R
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30081552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
